- Tytuł:
- Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
- Autorzy:
- Źródło:
- In The Lancet 10-16 July 2021 398(10295):121-130
Czasopismo naukowe